Dacogen is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Otsuka America Pharmaceutical, Inc.. The primary component is Decitabine.
| Product ID | 59148-046_4d5b6a30-b467-4236-bef9-4c339aab5921 |
| NDC | 59148-046 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Dacogen |
| Generic Name | Decitabine |
| Dosage Form | Injection, Powder, Lyophilized, For Solution |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2006-05-02 |
| Marketing Category | NDA / NDA |
| Application Number | NDA021790 |
| Labeler Name | Otsuka America Pharmaceutical, Inc. |
| Substance Name | DECITABINE |
| Active Ingredient Strength | 50 mg/20mL |
| Pharm Classes | Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |
| Marketing Start Date | 2006-05-02 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA021790 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2006-05-02 |
| Ingredient | Strength |
|---|---|
| DECITABINE | 50 mg/20mL |
| SPL SET ID: | deb4a13c-855b-4372-9778-6e81da598df6 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 59148-046 | Dacogen | decitabine |
| 0143-9385 | decitabine | decitabine |
| 0781-3139 | Decitabine | Decitabine |
| 0781-3296 | Decitabine | Decitabine |
| 16714-749 | Decitabine | Decitabine |
| 16714-928 | Decitabine | Decitabine |
| 16729-224 | Decitabine | decitabine |
| 25021-231 | decitabine | decitabine |
| 42737-110 | Decitabine | Decitabine |
| 43598-348 | Decitabine | Decitabine |
| 43598-427 | Decitabine | Decitabine |
| 47335-361 | decitabine | decitabine |
| 50742-430 | DECITABINE | decitabine |
| 55111-556 | Decitabine | Decitabine |
| 55150-376 | Decitabine | Decitabine |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() DACOGEN 78216191 3197209 Live/Registered |
ASTEX PHARMACEUTICALS, INC. 2003-02-18 |